#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Prostate cancer Obesity Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Malignant melanoma Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rett syndrome Amyotrophic lateral sclerosis gene carrier Exudative retinopathy Cardiac sarcoidosis Myeloid leukaemia Primary amyloidosis Hidradenitis Fusarium infection Encephalitis autoimmune Thromboangiitis obliterans Oesophageal squamous cell carcinoma stage II Dupuytren's contracture Transitional cell carcinoma Peritoneal neoplasm Osteochondrodysplasia More trials…

    Learn about Rare Diseases

    Bronchiolitis obliterans syndrome – Basic Information Nephroblastoma – Diagnostics Prader-Willi syndrome – Treatment Mucopolysaccharidosis Sarcoma – Life with Disease Ewing’s sarcoma metastatic – Life with Disease Hereditary neuropathic amyloidosis – Life with Disease Primary biliary cholangitis – Basic Information Synovial sarcoma recurrent – Life with Disease Activated PI3 kinase delta syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Talquetamab Tamoxifen Clobetasol Glepaglutide Cefuroxime Human Serum Albumin 5% Anb032 Carbetocin Omeprazole Bexotegrast Mosaic Hbcoreag Amsacrine Polatuzumab Vedotin ULTEVURSEN CICLOPIROX Tetracaine Hydrochloride Mepacrine Regn7257 YOHIMBINE HYDROCHLORIDE Amb-05X More therapies…

    Learn about Your Condition

    Oesophageal atresia Marfan's syndrome Hepatitis D Colon cancer stage IV Chorioretinitis Immune-mediated renal disorder Lymphangioleiomyomatosis Trisomy 21 Ophthalmoplegia Haemorrhage Short-bowel syndrome Metastatic gastric cancer Progressive multiple sclerosis Skin papilloma Medulloblastoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Latvia

  • Efficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial

    Recruiting

    4 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • LUNSEKIMIG
    Belgium Denmark Estonia Finland France Germany +7

  • Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis

    Recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Croatia Czechia France Greece Hungary Italy +5

  • Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

    Recruiting

    4 1
    Investigated Drugs:
    • Clazakizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Randomized Study of Intravitreal mk-8748 Compared with Aflibercept in Patients with Neovascular Age‑Related Macular Degeneration

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Aflibercept
    Estonia Germany Latvia Poland Spain

  • GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents

    Recruiting

    3 1
    Investigated Diseases:
    • Asthma
    Bulgaria Croatia Czechia Germany Greece Hungary +4

  • A Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Etoposide
    • Igg-Like T Cell Engager Binding To Dll3 And Cd3
    Austria Belgium Bulgaria Czechia Estonia Finland +14
1 2 3 … 33
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Sodium Chloride Aflibercept Cisplatin Carboplatin Zasocitinib Apixaban Risankizumab Pemetrexed Hydrocortisone Aztreonam Inclisiran Enoxaparin Sodium Ranibizumab Fluorescein Sodium Upadacitinib Fluorouracil Milvexian Somapacitan Somatropin Vedolizumab Apremilast Guselkumab Mirikizumab Abelacimab Ofatumumab Efgartigimod Alfa Etoposide Olaparib Methotrexate Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Abdominal infection Acromegaly Acute coronary syndrome Acute haemorrhagic ulcerative colitis Acute myeloid leukaemia Acute myocardial infarction Adenocarcinoma gastric Adrenogenital syndrome Age-related macular degeneration Amyotrophic lateral sclerosis Appendicitis Arteriosclerosis Aspergillus infection Asthma Atrial fibrillation Bladder cancer Breast cancer Bronchiectasis Cardiac failure Cardiac failure chronic Cardiovascular disorder Cerebral palsy Cerebrovascular accident prophylaxis Choroidal neovascularisation Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic obstructive pulmonary disease Chronic spontaneous urticaria Cold urticaria Colitis ulcerative Colorectal cancer metastatic Conjunctivitis allergic COVID-19 Crohn's disease Dermatitis atopic Diabetic foot infection Diabetic gastroparesis Diabetic retinal oedema Diabetic retinopathy Dry age-related macular degeneration Dyslipidaemia Ectopic pregnancy Embolism Embolism venous Endocrine ophthalmopathy Endometriosis Epileptic encephalopathy Factor VIII deficiency Gastric cancer Gastrointestinal cancer metastatic Generalised tonic-clonic seizure Glioblastoma Glioblastoma multiforme Growth hormone deficiency Haemophilia A with anti factor VIII Hormone-refractory prostate cancer Hypercholesterolaemia Hypertension Hypertriglyceridaemia Immune thrombocytopenia Impaired gastric emptying Infection prophylaxis Interstitial lung disease Iron deficiency Ischaemic stroke Lennox-Gastaut syndrome Lower respiratory tract infection Macular oedema Major depression Measles immunisation Metastatic malignant melanoma Multifocal motor neuropathy Multiple sclerosis Multiple sclerosis relapse Muscle spasticity Neoplasm Neoplasm malignant Neovascular age-related macular degeneration Nephropathy Neurodermatitis Neurogenic bladder Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer stage IV Noonan syndrome Obesity Oesophageal adenocarcinoma Osteoporosis postmenopausal Ovarian cancer Partial seizures Pemphigoid Plasma cell myeloma Pneumonia Pneumonia bacterial Progressive relapsing multiple sclerosis Prostate cancer metastatic Psoriasis Psoriatic arthropathy Pulmonary arterial hypertension Pulmonary hypertension Pyelonephritis Pyelonephritis acute Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Renal cell carcinoma Retinal vein occlusion Rheumatoid arthritis Rhinitis allergic Secondary progressive multiple sclerosis Severe myoclonic epilepsy of infancy Short stature Skin bacterial infection Skin cancer Small cell lung cancer Small for dates baby Squamous cell carcinoma of head and neck Systemic lupus erythematosus Thrombosis prophylaxis Transient ischaemic attack Transitional cell cancer of the renal pelvis and ureter Transitional cell carcinoma Triple negative breast cancer Turner's syndrome Type 2 diabetes mellitus Urinary tract infection Varicella immunisation

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!